There are a number of nonopioid options, as well as nondrug options, for pain management, explained Jeff White, PharmD, MS, staff vice president, Anthem.
There are a number of nonopioid options, as well as nondrug options, for pain management, explained Jeff White, PharmD, MS, staff vice president, Anthem.
Transcript
What are some available nonopioid options to pain management?
There are a number of nonopioid options to pain management. It’s important to start with the evidence to understand the true clinical benefits and harms of therapy, and that will guide the alternatives. There’s a substantial amount of evidence to support nonopioid therapies. For example, there are the NSAIDS [nonsteroidal anti-inflammatory drugs], such as Motrin or Naprosyn. There are also antidepressants, there are also anticonvulsants such as gabapentin, and there’s other topical therapies, and many others to help treat pain.
It’s important to guide the therapy towards the type of pain for which there’s evidence to support use for that particular condition. There’s also a number of nondrug-related options to address and manage pain. For example, there’s physical therapy, there’s exercise and stretching, acupuncture, yoga, and a number of other evidence-based nondrug alternatives.
Are there any misconceptions about these alternatives?
A common misconception is that pain needs to be treated with an opioid when there’s limited evidence on the long-term safety and efficacy of opioid therapy. Whereas the nonopioid alternatives, there’s strong evidence to support long-term safety and efficacy of those drugs.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen